主要文件

查看所有文档

C32607

2-氯环己酮

Name: 2-氯环己酮
Brand: ALDRICH

98%

别名:

α-Chlorocyclohexanone, (±)-2-Chloro-1-cyclohexanone, (±)-2-Chlorocyclohexanone, 2-Chlorocyclohexan-1-one, 2-Chlorocyclohexanone

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:

ClC₆H₉(=O)

化学文摘社编号:

822-87-7

分子量:

132.59

UNSPSC Code:

12352100

NACRES:

NA.22

PubChem Substance ID:

24892597

EC Number:

212-505-5

Beilstein/REAXYS Number:

774100

MDL number:

MFCD00001626

Assay:

98%

Form:

solid

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

Quality Level

100

assay

98%

form

solid

refractive index

n20/D 1.484 (lit.)

bp

82-83 °C/10 mmHg (lit.)

mp

23 °C (lit.)

density

1.161 g/mL at 25 °C (lit.)

storage temp.

2-8°C

SMILES string

ClC1CCCCC1=O

InChI

1S/C6H9ClO/c7-5-3-1-2-4-6(5)8/h5H,1-4H2

InChI key

CCHNWURRBFGQCD-UHFFFAOYSA-N

说明

pictograms

GHS07

signalword

Warning

hcodes

H315,H317,H319,H335

pcodes

P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

target_organs

Respiratory system

存储类别

11 - Combustible Solids

flash_point_f

179.6 °F - closed cup

flash_point_c

82 °C - closed cup

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

alpha-chloroepoxides. 2. Mutagenicity of 1-chlorocyclohexene oxide and its thermal isomerization product, 2-chlorocyclohexanone.

B Gold et al.

Chemico-biological interactions, 45(3), 305-314 (1983-08-01)

The pseudo-first-order hydrolysis rate constants in pH 7.4 buffer-acetone solution are reported for 1-chlorocyclohexene oxide and 2-chlorocyclohexanone at 0, 25 and 37 degrees C. The rate constants, in conjunction with product studies, demonstrate that the hydrolysis of 1-chlorocyclohexane oxide quantitatively

Synthesis of micellar-like terpolymer nanoparticles with reductively-cleavable cross-links and evaluation of efficacy in 2D and 3D models of triple negative breast cancer.

Patrícia F Monteiro et al.

Journal of controlled release : official journal of the Controlled Release Society, 323, 549-564 (2020-05-07)

Triple negative or basal-like breast cancer (TNBC) is characterised by aggressive progression, lack of standard therapies and poorer overall survival rates for patients. The bad prognosis, high rate of relapse and resistance against anticancer drugs have been associated with a

全球贸易项目编号

货号	GTIN
C32607-100G	04061833485637
C32607-25G	04061831826135
C32607-5G	04061831826142